Avanos Medical (AVNS)
(Delayed Data from NYSE)
$12.28 USD
+0.42 (3.54%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $12.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, AVANOS MEDICAL, INC. has a PEG ratio of 1.29 compared to the Medical - Instruments industry's PEG ratio of 2.28.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AVNS 12.28 +0.42(3.54%)
Will AVNS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
New Strong Sell Stocks for July 15th
Other News for AVNS
AVNS forms Directional Movement Crossover Bullish on September 18
Is AVNS primed for downward momentum? Fell Below 20 Day Moving Average shows up after slipping 3.1%
Is AVNS poised for a decline? Shooting Star Candlestick shows up after climbing 0.41%
Avanos (AVNS) Acquires Nexus Medical to Expand Device Portfolio
Avanos Medical Acquires Nexus Medical for Growth